NOVA ADVANCED TISSUE ENGINEERING LIMITED
NOVA ADVANCED TISSUE ENGINEERING LIMITED is a private limited company registered in the United Kingdom, under 11083393, incorporated on 27 November 2017. The company is currently active. Operates in the dormant company sector (SIC 99999). The company has been operating for 8 years. Registered office address: LE18 4YL Wigston, the United Kingdom. Directors include MRS KAREN ALISON LEISHMAN, MR JAMES ANDREW PITT WHITE, and DR PETER JOHN PITT WHITE. Sole shareholder is NOVA BIO-PHARMA HOLDINGS LIMITED. Associated with 11 related entities, including 06951295, NOVA BIO-PHARMA HOLDINGS LIMITED, and NOVA IMMUNOTHERAPEUTICS LIMITED. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Registered Address
MARTIN HOUSE
GLOUCESTER CRESCENT
LEICESTERSHIRE
LE18 4YL WIGSTON
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Source Records (1)
| companieshouse | 11083393 | 2026-06-01 | open_in_new |